ETHYL 4-(4-AMINOPHENYL)PIPERAZINE-1-CARBOXYLATE
|
- $362 - $502.7
- Product name: ETHYL 4-(4-AMINOPHENYL)PIPERAZINE-1-CARBOXYLATE
- CAS: 16154-70-4
- MF: C13H19N3O2
- MW: 249.31
- EINECS:
- MDL Number:MFCD11848963
- Synonyms:4-(4-AMINOPHENYL)-1-PIPERAZINECARBOXYLIC ACID ETHYL ESTER;ETHYL 4-(4-AMINOPHENYL)PIPERAZINE-1-CARBOXYLATE;Ethyl 4-(4-aminophenyl)tetrahydro-1(2H)-pyrazinecarboxylate;1-Piperazinecarboxylic acid, 4-(4-aminophenyl)-, ethyl ester
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 5MG
- 500mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0392463
- Product descriptionETHYL-4-(4-AMINOPHENYL)PIPERAZINE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$502.7
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number043705
- Product descriptionEthyl 4-(4-aminophenyl)tetrahydro-1(2H)-pyrazinecarboxylate >95%
- Packaging500mg
- Price$362
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number043705
- Product descriptionEthyl 4-(4-aminophenyl)tetrahydro-1(2H)-pyrazinecarboxylate >95%
- Packaging1g
- Price$454
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0392463 | ETHYL-4-(4-AMINOPHENYL)PIPERAZINE-1-CARBOXYLATE 95.00% | 5MG | $502.7 | 2021-12-16 | Buy |
| Matrix Scientific | 043705 | Ethyl 4-(4-aminophenyl)tetrahydro-1(2H)-pyrazinecarboxylate >95% | 500mg | $362 | 2021-12-16 | Buy |
| Matrix Scientific | 043705 | Ethyl 4-(4-aminophenyl)tetrahydro-1(2H)-pyrazinecarboxylate >95% | 1g | $454 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|